IRIS
DENTONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.485
Totale 5.485
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.485
Totale 5.485
Salva come PNG Salva come JPEG
Città #
Genova 3.095
Rapallo 1.049
Genoa 1.035
Vado Ligure 267
Bordighera 39
Totale 5.485
Salva come PNG Salva come JPEG
Nome #
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 185
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 170
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 154
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 149
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 148
A Standard Interface for Data Reuse in Infectious Diseases 143
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 138
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 130
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 125
Use of colistin in adult patients: a cross-sectional study 124
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 123
A comparison of inpatient admissions in 2012 from two European countries 122
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 112
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 112
Web interaction to improve collaboration in monitoring of microbial infections 106
Use of maraviroc in clinical practice: a multicenter observational study 105
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 102
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 100
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 97
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 95
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 87
Weight gain: A possible side effect of all antiretrovirals 86
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 85
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 84
Bloodstream infections in critically ill patients with COVID-19 84
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 83
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 82
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 81
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 79
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 78
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 77
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 74
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 68
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 68
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 67
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 66
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 66
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 65
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 62
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 62
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 59
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 57
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 57
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 56
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 56
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 54
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 53
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 51
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 50
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 49
The Ligurian HIV network: How medical informatics standards can help clinical research 49
A very rare case of mycobacterium gordonae infection of the breast 48
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 48
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 46
Characterization of T lymphocytes in severe COVID-19 patients 46
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 45
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 44
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 43
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 40
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 40
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 35
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 35
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 34
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 32
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 32
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 31
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 30
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 29
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 27
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 26
Factors Associated With Weight Gain in People Treated With Dolutegravir 24
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 23
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 23
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 22
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 22
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 22
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 22
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 21
Behind the screens: Clinical decision support methodologies - A review 21
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 20
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 19
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 16
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 16
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 15
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 14
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 13
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 12
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 4
Totale 5.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.280
article - articoli 21.160
book - libri 0
conference - conferenze 2.932
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 188
Totale 48.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020988 0 0 0 74 86 137 171 82 112 181 115 30
2020/2021547 21 39 52 54 42 56 43 49 44 61 36 50
2021/2022789 31 35 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/2025310 80 146 60 24 0 0 0 0 0 0 0 0
Totale 5.675